BSH 2019 | CAR-T for ALL: access, eligibility & toxicity

Sara Ghorashian

Sara Ghorashian, PhD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK, discusses the barriers to CAR T-cell therapy for acute lymphoblastic leukemia (ALL) patients. She also explains the patient selection criteria and side effects. This interview took place at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.

Share this video